I-Diclofenac+Paracetamol+Serratiopeptidase iyinhlanganisela yemithi esetshenziselwa ukwelapha ubuhlungu nokuvuvukala ezifweni ezinjenge-osteoarthritis, rheumatoid arthritis, i-ankylosing spondylitis, ubuhlungu bamazinyo, nobuhlungu bangemva kokuhlinzwa. Umuthi uqukethe i-Diclofenac, okuyisidakamizwa esingeyona i-steroidal eqeda ukuvuvukala (NSAID) esinciphisa ubuhlungu nokuvuvukala, iParacetamol, okuyisidakamizwa esidambisa izinhlungu nomkhuhlane, kanye neSerratiopeptidase, okuyi-enzyme enciphisa ukuvuvukala futhi ithuthukise ukuphulukiswa kwezicubu.
I-Diclofenac+Paracetamol+Serratiopeptidase iyinhlanganisela yezinto ezintathu ezisetshenziswa njalo ubuhlungu nezidakamizwa ezivuthayo. Ngezansi ezimbalwa zezicelo zalesi sidakamizwa ziqonde ngqo:
Kumele kuqashelwe ukuthi lesi sidakamizwa kufanele sisetshenziswe njengoba kuphakanyiswe uchwepheshe wezokwelapha hhayi njengendlela yokuzilapha.
Inhlanganisela ye-Diclofenac, i-Paracetamol, ne-Serratiopeptidase kumaphilisi inikeza izinzuzo eziningana:
I-Diclofenac+Paracetamol+Serratiopeptidase umuthi odambisa izinhlungu, wehlise ukuvuvukala, futhi welapha izifo zokuphefumula kanye ne-sinusitis. Ngokuvamile isetshenziswa ngokudla noma ngaphandle kokudla, futhi inani nobude besikhathi somuthi kungahluka kuye ngokugula okwelashwa. Akufanele igaywe, ihlafunwe, noma iphulwe futhi kufanele idliwe ngokuphelele ngamanzi. Kubalulekile ukulandela iziqondiso zochwepheshe bezempilo noma ilebula yemithi. Bazise nganoma yimiphi eminye imithi noma izimo zezokwelapha, futhi ungeqi isilinganiso esinconyiwe noma ubude besikhathi sokwelashwa.
Kungase kube nemiphumela emibi evamile ye-Diclofenac+Paracetamol+Serratiopeptidase, njenge
Ngokuvamile, imiphumela emibi iyaphela ngemva kwesikhathi esithile. Kodwa uma izimpawu ziba zimbi, kufanele ubone udokotela wakho.
Yazisa udokotela wakho uma ungezwani nomuthi. Ngisho noma ungezwani neminye imithi, kufanele uxoxe ngayo nodokotela wakho.
Uma uphuthelwa umthamo we-Diclofenac+Paracetamol+Serratiopeptidase, ungayithatha uma ukhumbula. Uma umthamo olandelayo uzodingeka maduze, kufanele weqe umthamo ogejiwe. Ukuthatha umthamo ophindwe kabili ukuze wenze umthamo ophuthelwe akunconywa.
Ukweqisa kwe-Diclofenac+Paracetamol+Serratiopeptidase kungaba yingozi futhi kungase kubangele imiphumela emibi kakhulu. Izimpawu zingabandakanya isicanucanu, ukuhlanza, ubuhlungu besisu, isifo sohudo, isiyezi, ukozela, ukudideka, ukuphefumula kanzima, nokuquleka. Thola usizo lwezokwelapha ngokushesha futhi ungeqi umthamo onconywayo.
I-Diclofenac+Paracetamol+Serratiopeptidase ingase ihlanganyele neminye imithi, ithinte indlela esebenza ngayo futhi yandise ingozi yemiphumela emibi. Yazisa udokotela wakho uma unemithi eqhubekayo, kuhlanganise nemithi etholakala ngaphandle kwe-counter, amavithamini, noma izithasiselo zemithi. Ukwengeza, gwema ukuphuza le mithi nezinye izidakamizwa ezingezona ukuvuvukala (ama-NSAID) noma izidakamizwa zegazi, njengoba zingandisa ingozi yokopha.
I-Diclofenac, i-paracetamol, namaphilisi e-serratiopeptidase angase angafaneleki kubantu abathile ngenxa yezizathu ezihlukahlukene. Nazi ezinye izinto zokuthi ubani okungafanele aphuze lawa maphilisi:
I-Diclofenac+Paracetamol+Serratiopeptidase umuthi osebenza ngokushesha, futhi abanye abantu bangase babone ukuncipha kwezimpawu zabo phakathi namahora ambalwa ngemva kokuphuza imithi.
Umthamo wamaphilisi e-Diclofenac + Paracetamol + Serratiopeptidase ungahluka kuye ngezici ezifana nokwakheka okuqondile, ubunzima besimo esiphathwayo, kanye nomlando wezokwelapha wesiguli ngasinye.
|
Ubudala Group |
Isidakamizwa |
Isikali |
|
Abantu abadala |
I-Diclofenac |
I-50 mg |
|
Asebekhulile |
I-Paracetamol |
I-325 mg |
|
Izingane |
I-Serratiopeptidase |
I-10 mg |
|
I-Diclofenac+Paracetamol+Serratiopeptidase |
Esgipyrin SP |
|
|
Ukubunjwa |
I-Diclofenac+Paracetamol+Serratiopeptidase iqukethe:
|
I-Esgipyrin SP iqukethe i-aspirin (isidakamizwa esilwa nokuvuvukala), i-Paracetamol, ne-caffeine. |
|
Usetshenziswa |
I-Diclofenac+Paracetamol+Serratiopeptidase isetshenziselwa ngokuyinhloko ukuphatha ubuhlungu nokuvuvukala ezimeni ezifana nesifo samathambo, ubuhlungu bangemva kokuhlinzwa, nobuhlungu bamazinyo. |
I-Esgipyrin SP iqeda ubuhlungu obuhambisana nekhanda, amajaqamba, ukuqaqamba kwamazinyo, nomkhuhlane. |
|
Okuqhamuka uma udla imishanguzo |
I-Diclofenac+Paracetamol+Serratiopeptidase ingase ibangele imiphumela engemihle njengokucanuzela kwenhliziyo, ukuhlanza, ubuhlungu besisu, isiyezi, nokungezwani nomzimba. |
I-Esgipyrin SP ingase ibangele imiphumela engemihle njengobuhlungu besisu, isilungulela, isicanucanu, isiyezi, nokungezwani komzimba. |
Le nhlanganisela ivame ukushiwo ukukhululeka kobuhlungu nokuvuvukala. I-Diclofenac iyisidakamizwa esingezona ukuvuvukala (i-NSAID), i-Paracetamol inikeza imiphumela ye-analgesic (edambisa izinhlungu), kanti i-Serratiopeptidase iyi-enzyme enezici zokuqeda ukuvuvukala.
I-Diclofenac inciphisa ukuvuvukala ngokuvimbela ukukhiqizwa kwe-prostaglandin, i-Paracetamol ikhulula ubuhlungu futhi inciphise umkhuhlane, kuyilapho i-Serratiopeptidase isiza ukudiliza nokususa izinto ezibangelwa ukuvuvukala.
Le nhlanganisela ijwayele ukusetshenziselwa ukuphatha ubuhlungu nokuvuvukala okuhambisana nezimo ezifana ne-osteoarthritis, i-rheumatoid arthritis, ubuhlungu bamazinyo, nobuhlungu bangemva kokuhlinzwa.
Yebo, le mithi ivamise ukunikezwa ndawonye ngenhlanganisela yomthamo ongashintshi ukuze kuthuthukiswe izinhlungu. Kodwa-ke, kubalulekile ukulandela imiyalelo yomhlinzeki wakho wokunakekelwa kwezempilo futhi ungazinqumeli wena.
Imiphumela emibi evamile ingase ihlanganise ukungakhululeki kwamathumbu, isicanucanu, nekhanda elibuhlungu. Uma uba nemiphumela engemihle enzima noma eqhubekayo, xhumana nomhlinzeki wakho wokunakekelwa kwezempilo.
Cha, i-diclofenac sodium ne-paracetamol awawona ama-antibiotic. I-Diclofenac iyisidakamizwa esingezona ukuvuvukala (i-NSAID) esisetshenziselwa ukunciphisa ubuhlungu nokuvuvukala, kuyilapho i-paracetamol (i-acetaminophen) iyisidambisi sobuhlungu kanye nokunciphisa umkhuhlane. Asebenza ngokuhlukile kuma-antibiotics, asetshenziselwa ukwelapha izifo ezibangelwa amagciwane.
Inhlanganisela ye-diclofenac, i-paracetamol, ne-serratiopeptidase ingabangela ukulimala kwezinso, ikakhulukazi kubantu abanezimo zezinso ezivele zikhona noma lapho besetshenziswa ngemithamo ephezulu noma isikhathi eside. Kubalulekile ukusebenzisa le mithi ngaphansi kokuqondisa kwezokwelapha futhi ulandele umthamo onqunyiwe ukuze unciphise ubungozi bemiphumela emibi ehlobene nezinso.
Ngokuvamile, akukho ukusebenzisana okubalulekile okwaziwayo phakathi kwe-diclofenac, i-paracetamol, i-serratiopeptidase, kanye nezithako eziyinkimbinkimbi zikavithamini B. Kodwa-ke, kuhlala kuhle ukuthi uxhumane nochwepheshe bezempilo ngaphambi kokuhlanganisa imithi noma izithasiselo ukuze uqinisekise ukuphepha futhi ugweme ukusebenzisana okungaba khona.
I-Diclofenac ne-paracetamol ingathathwa ndawonye, kodwa kubalulekile ukulandela iseluleko sezokwelapha mayelana nesilinganiso kanye nobude besikhathi sokusetshenziswa. Le mithi inezinqubo ezahlukene zokusebenza futhi ingaphelelisana ekunikezeni ukukhululeka ebuhlungwini nasekuvuvukeni. Kodwa-ke, ukuzihlanganisa kufanele kwenziwe ngaphansi kokuqondisa kodokotela ukuze kuqashwe imiphumela engemihle engaba khona, ikakhulukazi ehlobene nempilo yamathumbu noma yezinso.
References:
https://www.medicines.org.uk/emc/product/5909/smpc. https://www.drugs.com/search.php?searchterm=Diclofenac%2C+Paracetamol+and+Serratiopeptidase
Umshwana wokuzihlangula: Ulwazi olunikezwe lapha alwenzelwe ukufaka iseluleko esivela kuchwepheshe wezokunakekelwa kwempilo. Ulwazi aluhloselwe ukumboza konke ukusetshenziswa okungenzeka, imiphumela engemihle, izinyathelo zokuphepha, nokusebenzisana kwezidakamizwa. Lolu lwazi aluhloselwe ukuphakamisa ukuthi ukusebenzisa umuthi othile kufanelekile, kuphephile, noma kuyasebenza wena noma omunye umuntu. Ukungabi bikho kwanoma yiluphi ulwazi noma isexwayiso mayelana nomuthi akufanele kuhunyushwe njengesiqinisekiso esicacile esivela enhlanganweni. Sikweluleka ngokuqinile ukuthi uthintane nodokotela uma kukhona okukukhathazayo ngomuthi futhi ungalokothi usebenzise umuthi ngaphandle kwencwadi kadokotela.